OM icon

Outset Medical

10.91 USD
-0.15
1.36%
At close Apr 1, 4:00 PM EDT
1 day
-1.36%
5 days
-6.91%
1 month
8.88%
3 months
-37.83%
6 months
15.08%
Year to date
-37.83%
1 year
-65.03%
5 years
-98.80%
10 years
-98.80%
0
Funds holding %
of 7,398 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

118% more call options, than puts

Call options by funds: $159K | Put options by funds: $73K

33% more capital invested

Capital invested by funds: $17.6M [Q3] → $23.4M (+$5.74M) [Q4]

8% less funds holding

Funds holding: 80 [Q3] → 74 (-6) [Q4]

9.99% less ownership

Funds ownership: 50.05% [Q3] → 40.07% (-9.99%) [Q4]

29% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 24

29% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 17

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$45
312%
upside
Avg. target
$45
312%
upside
High target
$45
312%
upside

1 analyst rating

positive
0%
neutral
100%
negative
0%
RBC Capital
Shagun Singh
55% 1-year accuracy
37 / 67 met price target
312%upside
$45
Sector Perform
Reiterated
7 Jan 2025

Financial journalist opinion

Neutral
GlobeNewsWire
2 weeks ago
Outset Medical Announces One-for-Fifteen Reverse Stock Split
SAN JOSE, Calif., March 18, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced a one-for-fifteen reverse stock split (the “Reverse Stock Split”) of the Company's common stock, par value $0.001, which will become effective at 12:01 a.m. Eastern Time on Thursday, March 20, 2025. The Company's common stock will continue to trade under Outset's existing trading symbol, OM, on the Nasdaq Global Select Market (“Nasdaq”) on a split-adjusted basis when the market opens on Thursday, March 20, 2025, with the new CUSIP number 690145206.
Outset Medical Announces One-for-Fifteen Reverse Stock Split
Negative
Zacks Investment Research
1 month ago
Bears are Losing Control Over Outset Medical (OM), Here's Why It's a 'Buy' Now
Outset Medical (OM) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Bears are Losing Control Over Outset Medical (OM), Here's Why It's a 'Buy' Now
Positive
The Motley Fool
1 month ago
3 Cryptocurrencies That Could Be Better Buys Than Bitcoin Right Now
In 2025, Bitcoin (BTC -1.18%) has over-promised and under-delivered. After reaching $100,000 in December, Bitcoin looked like a no-brainer option to soar in value this year.
3 Cryptocurrencies That Could Be Better Buys Than Bitcoin Right Now
Neutral
GlobeNewsWire
1 month ago
Outset Medical to Present at the 45th Annual TD Cowen Health Care Conference
SAN JOSE, Calif., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will present at the 45th annual TD Cowen Health Care conference on Tuesday, March 4, 2025, at 2:30 p.m.
Outset Medical to Present at the 45th Annual TD Cowen Health Care Conference
Neutral
Seeking Alpha
1 month ago
Outset Medical, Inc. (OM) Q4 2024 Earnings Call Transcript
Outset Medical, Inc. (NASDAQ:OM ) Q4 2024 Earnings Conference Call February 19, 2025 5:00 PM ET Company Participants Jim Mazzola - Head of Investor Relations Leslie Trigg - Chair and CEO Nabeel Ahmed - Chief Financial Officer Conference Call Participants Marie Thibault - BTIG Shagun Singh - RBC Capital Markets Suraj Kalia - Oppenheimer Operator Good day, and thank you for standing by. Welcome to the Outset Medical Fourth Quarter 2024 Earnings Conference Call.
Outset Medical, Inc. (OM) Q4 2024 Earnings Call Transcript
Positive
The Motley Fool
1 month ago
Outset Medical: Profitability Path Brightens
Outset Medical (OM 3.52%), the innovator behind the Tablo Hemodialysis System, reported fourth-quarter earnings on Wednesday, Feb. 19, that topped analysts' consensus expectations on top and bottom lines. Fourth-quarter revenue of $29.5 million exceeded the forecasted $28 million, indicating resilience in revenue growth despite market hurdles.
Outset Medical: Profitability Path Brightens
Negative
Zacks Investment Research
1 month ago
Outset Medical, Inc. (OM) Reports Q4 Loss, Tops Revenue Estimates
Outset Medical, Inc. (OM) came out with a quarterly loss of $0.37 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to loss of $0.59 per share a year ago.
Outset Medical, Inc. (OM) Reports Q4 Loss, Tops Revenue Estimates
Neutral
GlobeNewsWire
1 month ago
Outset Medical Reports Fourth Quarter and Full Year 2024 Financial Results
SAN JOSE, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported financial results for the fourth quarter and full year ended December 31, 2024.
Outset Medical Reports Fourth Quarter and Full Year 2024 Financial Results
Neutral
GlobeNewsWire
1 month ago
Outset Medical Announces Resolution of Warning Letter
SAN JOSE, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced it has been notified by the Food and Drug Administration that all issues cited in a Warning Letter the company received in July of 2023 have been addressed.
Outset Medical Announces Resolution of Warning Letter
Negative
Zacks Investment Research
1 month ago
Outset Medical, Inc. (OM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Outset Medical (OM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Outset Medical, Inc. (OM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Charts implemented using Lightweight Charts™